The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: FTSE 100 boosted by miners as commodities rise

Fri, 04th Nov 2022 09:01

(Alliance News) - Stocks were higher in London early Friday, as mining stocks lifted the FTSE 100, buoyed by rumours of an end to China's zero-tolerance Covid policies.

The FTSE 100 index opened up 53.97 points, or 0.8%, at 7,242.60. The FTSE 250 was up 89.52, or 0.5% at 18,199.13, and the AIM All-Share was up 3.83 points, 0.5%, at 813.70.

The Cboe UK 100 was up 0.8% at 813.70, the Cboe UK 250 up 0.6% at 15,604.26, and the Cboe Small Companies up 4.2% at 12,363.42.

On Thursday, the Bank of England lifted the bank rate by 75 basis points, matching the Federal Reserve's hike of US rates on Wednesday. However, Governor Andrew Bailey's dovish remarks in the subsequent press conference were in stark contrast with the hawkishness of US counterpart Jerome Powell, putting pressure on sterling.

Bailey said UK interest rates will have to go up by "less than currently priced into financial markets". The benchmark rate currently stands at a 14-year high of 3.00%.

The BoE warned of a "very challenging outlook" for the UK economy. It expects UK gross domestic product to have contracted by 0.5% in the third quarter, before falling by 0.3% in the fourth.

It expects the UK economy to remain in recession throughout next year and into the first half of 2024. It only predicts a "gradual recovery" in GDP thereafter.

Focus will be on the US nonfarm payrolls report due at 1230 London time, an hour earlier than normal for European markets due to the time change in Europe and the UK this week. The US labour market is expected to have added 200,000 jobs last month, according to consensus cited by FXStreet. That outcome would be a slowdown from 263,000 in September.

"If the expected number of 200,000 jobs being added is exceeded and the unemployment rate more or less unchanged, this will add further fuel to the Fed’s policy. This is despite the fact that the release would signal a drop from the previous month’s reading of 263000, with the simple reality being that until unemployment begins to rise and the consumer therefore spends less, a lessening of inflation could remain out of reach, said interactive investor's Richard Hunter.

The dollar was mixed ahead of the US unemployment reading.

Sterling was quoted at USD1.1211 early Friday, higher than USD1.1184 at the London equities close on Thursday. The euro traded at USD0.9774 early Friday, higher than USD0.9754 late Thursday. Against the yen, the dollar was quoted at JPY147.67, up versus JPY147.08.

In European equities on Friday, the CAC 40 in Paris was up 0.8%, while the DAX 40 in Frankfurt was up 0.7%.

In Tokyo on Friday, Nikkei 225 stock index was down 1.7%. The S&P/ASX 200 in Sydney was up 0.5%.

Meanwhile stocks in China rallied, as the Shanghai Composite closed up 2.4%, while the Hang Seng index in Hong Kong was up 5.4%. This follows unsubstantiated speculation that China is preparing to roll back its zero-Covid measures.

"The limitations and lockdowns, which have exacerbated a decline in consumer confidence and a faltering property market, have crimped demand which has not only hampered the Chinese economy, but has also tipped over into other asset classes such as commodities and oil," said ii's Hunter.

Gold was quoted at USD1,647.45 an ounce early Friday in London, higher than USD1,625.97 late Thursday. Brent oil was trading at USD96.29 a barrel, higher than USD95.21.

London's blue-chip miners were doing well in early trading, tracking the price of commodities higher. Anglo American was up 5.1%, Rio Tinto up 4.1%, Glencore up 3.1%, Fresnillo up 3.2%, Endeavour Mining up 2.6% and Antofagasta up 2.9%.

AstraZeneca said its respiratory syncytial virus treatment Beyfortus, or nirsevimab, which it develops with French partner Sanofi, has received EU approval for prevention of the virus in newborns and infants.

The news follows a September recommendation from the European Medicines Authority's Committee for Medicinal Products for Human Use.

AstraZeneca was up 1.6%, while Sanofi was up 0.1% in Paris.

J Sainsbury gave back some of Thursday's gains, after the stock was cut to 'neutral' from 'outperform' by Exane BNP. It was down 2.2% in early trading, having closed up 7.1% on Thursday after a well-received set of interim results.

Among London mid-caps, Morgan Advanced Materials jumped 12%.

The advanced carbon and ceramic materials manufacturer upgraded annual guidance after a strong year-to-date.

It said sales in the nine months to September were up 11% year-on-year, on an organic constant currency basis. Morgan said revenue remains "robust", but notes a "slight moderation" in growth rates in the third quarter, in light of the wider economic challenges.

However, it now expects full-year organic constant currency growth to be between 7% to 9% higher than previous guidance, and expects adjusted operating profit to be "marginally above" the top end of market consensus.

4imprint was close behind, adding 8.3%, after it said trading in the year so far has gone well, and it expects annual revenue to be around USD1.1 billion.

Noting "consistent productivity from [its] marketing activities, relative stability in gross margins and operational leverage over the fixed and semi-fixed elements of the cost base", it now expects pretax profit for 2022 to be at the top end of current market consensus, and "not less than USD90 million".

"Looking forward, the board remains confident in and committed to the group's strategy, positioning and prospects," the promotional merchandise firm said.

"4imprint has resolutely proved that it has once again emerged from an economic downturn in a stronger position, accelerating market share gains," said finncap's Guy Hewett.

Smallcap sofa seller DFS Furniture added 5.2%, as it reported better market conditions.

Having warned of a markedly softed upholstery market since from April to September, it said the trend has been more positive since then. Group order volumes are up from the previous year, and also compared to pre-pandemic financial 2019, DFS said.

It said trading is in line with its mid case scenario of GBP36 million pre-tax profit for the full year, with profit likely to be weighted in the second half.

"Whilst the macroeconomic outlook is uncertain and inflationary pressures remain high...Our business has proven to be resilient, and given our inherent strengths, we are well positioned to maintain our trend of market share gains across the economic cycle," DFS said.

On AIM, Thor Mining jumped 19%.

Thor Mining said drilling returned "high grade" gold from the silicified altered contact along Kelly's Ridge, at the Ragged Range in Eastern Pilbara, Western Australia.

It reports the best intercept to date of 4 metres at 12.2 grammes per tonne gold from 194 metres.

"This confirms the potential of the site as indicated by historical drilling. Furthermore, with more drilling results to come, we are looking forward to gaining further understanding of the project. We anticipate more positive news to be shared with the market in due course," said Managing Director Nicole Galloway Warland.

In the global economic calendar on Friday, there are a slew of services PMIs, including Germany and the eurozone. There is a eurozone producer price reading at 1000 GMT, before the latest US nonfarm payrolls report at 1230 GMT

By Elizabeth Winter; elizabethwinter@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.